Cargando…

A Single Intramuscular Vaccination of Mice with the HSV-1 VC2 Virus with Mutations in the Glycoprotein K and the Membrane Protein UL20 Confers Full Protection against Lethal Intravaginal Challenge with Virulent HSV-1 and HSV-2 Strains

Herpes Simplex Virus type-1 (HSV-1) and type-2 (HSV-2) establish life-long infections and cause significant orofacial and genital infections in humans. HSV-1 is the leading cause of infectious blindness in the western world. Currently, there are no available vaccines to protect against herpes simple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanfield, Brent A., Stahl, Jacque, Chouljenko, Vladimir N., Subramanian, Ramesh, Charles, Anu-Susan, Saied, Ahmad A., Walker, Jason D., Kousoulas, Konstantin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211657/ https://www.ncbi.nlm.nih.gov/pubmed/25350288 http://dx.doi.org/10.1371/journal.pone.0109890

Ejemplares similares

Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis
por: Naidu, Shan K., et al.
Publicado: (2020)

Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
por: Iyer, Arun V, et al.
Publicado: (2013)

Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration
por: Nabi, Rafiq, et al.
Publicado: (2021)

Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1(VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF
por: Clark, Carolyn M., et al.
Publicado: (2023)

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2022)

Molecular docking analysis of a secondary metabolite with the glycoprotein receptors of HSV 1 and HSV 2
por: Saran, Natarajan, et al.
Publicado: (2019)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Negative epidemiological association between HSV-1 and HSV-2 infections
por: Nasrallah, Gheyath K., et al.
Publicado: (2019)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
por: Casto, Amanda M., et al.
Publicado: (2020)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2014)

The HSV-1 Exonuclease, UL12, Stimulates Recombination by a Single Strand Annealing Mechanism
por: Schumacher, April J., et al.
Publicado: (2012)

Viral UL8 Is Involved in the Antiviral Activity of Oleanolic Acid Against HSV-1 Infection
por: Shan, Tianhao, et al.
Publicado: (2021)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity
por: Allen, Sariah J., et al.
Publicado: (2014)

Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens
por: Granato, Paul A., et al.
Publicado: (2015)

Correction: IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
por: Johnson, Karen E., et al.
Publicado: (2018)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
por: Välimaa, Hannamari, et al.
Publicado: (2009)

Subcellular Trafficking and Functional Relationship of the HSV-1 Glycoproteins N and M
por: Striebinger, Hannah, et al.
Publicado: (2016)

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
por: Hassan, Sherif T. S., et al.
Publicado: (2019)

HSV-1 latent rabbits shed viral DNA into their saliva
por: Hill, James M, et al.
Publicado: (2012)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

HSV-1 Cytoplasmic Envelopment and Egress
por: Ahmad, Imran, et al.
Publicado: (2020)

The UL16 protein of HSV-1 promotes the metabolism of cell mitochondria by binding to ANT2 protein
por: Li, Shiyu, et al.
Publicado: (2021)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
por: Goswami, Poorna, et al.
Publicado: (2022)

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
por: Han, Mingqi, et al.
Publicado: (2019)

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer
por: Nabi, Rafiq, et al.
Publicado: (2023)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2021)

Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice
por: Israyelyan, Anna, et al.
Publicado: (2008)

In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease
por: Aubert, Martine, et al.
Publicado: (2014)

Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate
por: Gandy, Lauren A., et al.
Publicado: (2022)

HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition
por: Gmyrek, Grzegorz B., et al.
Publicado: (2022)

LAT Region Factors Mediating Differential Neuronal Tropism of HSV-1 and HSV-2 Do Not Act in Trans
por: Bertke, Andrea S., et al.
Publicado: (2012)

Anti-herpetic Activity of Macrocystis pyrifera and Durvillaea antarctica Algae Extracts Against HSV-1 and HSV-2
por: Castillo, Estefanía, et al.
Publicado: (2020)

Simultaneous detection of HSV-1, HSV-2 and VZV in clinical samples by multiplex polymerase chain reaction (MPCR)
por: Sharifzad, F., et al.
Publicado: (2006)

A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV
por: Lince, Kimberly C, et al.
Publicado: (2023)

Detection of HSV-1, HSV-2 and VZV Isolated from Cerebrospinal Fluid Samples of Children Suspected to Encephalitis
por: Dehghan, Golnaz, et al.
Publicado: (2023)

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
por: Qin, Shurong, et al.
Publicado: (2022)

Oleanolic Acid Derivative AXX-18 Exerts Antiviral Activity by Inhibiting the Expression of HSV-1 Viral Genes UL8 and UL52
por: Wang, Zhaoyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tauf8jnvgdgh2169q2nelfr2t